On Oct. 9, 2007, the David H. Koch Institute for Integrative Cancer Research at MIT was established with…
On Sept. 23, 2007, the Stanford Cancer Institute (SCI) was awarded “cancer center” designation from the National Cancer…
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
On Sept. 10, 2007, the National Cancer Institute (NCI) awarded a five-year, $12.5 million Specialized Program of Research…
On Jul. 15, 2007, Dr. Jim Olson and colleagues from Fred Hutchinson Cancer Research Center and Seattle Children’s…
On Jun. 14, 2007, the National Cancer Institute (NCI) launched the 3-year pilot phase of a new program…
On May 15, 2007, the University of New Mexico Cancer Center broke ground on new state-of-the-art cancer treatment…
On May 8, 2007, the National Cancer Institute (NCI) reported that people infected with the hepatitis C virus…
On Apr. 20, 2007, the National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 allowed…
On Apr. 18, 2007, a study led by the University of Texas M.D. Anderson Cancer Center reported that…
On Apr. 1, 2007, National Cancer Institute (NCI) researchers reported that a variation in a portion of DNA…
On Mar. 28, 2007, Magnetic Resonance Imaging (MRI) scans of women who were diagnosed with cancer in one…
On Feb. 8, 2007, Oregon Health & Science University (OHSU) and the OHSU Foundation announced the largest outright gift…
On Jan. 23, 2007, results from a large phase III clinical trial show that adult patients with previously…
In 2007, the U.S. Congress declared May National Cancer Control Month, an opportunity to educate all Americans about…
In 2007, The St. Jude LIFE study on the long-term effects of cancer and its treatment began. This…
In 2007, Texas voters overwhelmingly approved a constitutional amendment that established the Cancer Prevention and Research Institute of…
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
On Sept. 15, 2006, the Oklahoma Medical Research Foundation (OMRF) celebrated it’s 60th anniversary. More than 600 people…
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
On Aug. 16, 2006, President Bush announced that he intended to appoint John E. Niederhuber, M.D., to be…
On Jul. 18, 20006, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement…
On Jun. 7, 2006, gene profiling, a molecular technique that examines many genes simultaneously, can accurately distinguish between…
On May 23, 2006, the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, was launched to examine…
On May 5, 2006, the Cancer Research Initiative was established in South Carolina, between MUSC, University of South…